Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent Mechanism

Diabetes - United States
doi 10.2337/db11-1073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1: Incretin Actions Beyond the Pancreas

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Caveolin-1 Peptide Exerts Cardioprotective Effects in Myocardial Ischemia-Reperfusion via Nitric Oxide Mechanism

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation Through a Calcium and AMPK Dependent Mechanism

PLoS ONE
Multidisciplinary
2014English

Glucagon-Like Peptide 1 Shows Glucose Dependence in Regulating Islet Hormone Secretion

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Protective Roles of the Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insolinotropic Polypeptide Hormones in Neurodegeneration

2011English

Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Analogues as Novel Treatments for Alzheimer’s and Parkinson’s Disease

Cardiovascular Endocrinology
2016English

Glucagon‑like Peptide‑1 Potentiates Glucose‑stimulated Insulin Secretion via the Transient Receptor Potential Melastatin 2 Channel

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy